IRIS
CIABATTINI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.150
EU - Europa 5.673
AS - Asia 2.972
SA - Sud America 535
Continente sconosciuto - Info sul continente non disponibili 215
AF - Africa 169
OC - Oceania 6
Totale 15.720
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.013
IT - Italia 1.387
RU - Federazione Russa 1.240
SG - Singapore 937
CN - Cina 909
GB - Regno Unito 714
IE - Irlanda 637
BR - Brasile 418
DE - Germania 335
VN - Vietnam 331
SE - Svezia 321
FI - Finlandia 274
FR - Francia 272
HK - Hong Kong 248
UA - Ucraina 217
KR - Corea 166
IN - India 102
ZA - Sudafrica 98
CA - Canada 75
BD - Bangladesh 60
ES - Italia 48
NL - Olanda 43
PL - Polonia 42
AR - Argentina 35
IQ - Iraq 28
MX - Messico 28
BE - Belgio 24
UZ - Uzbekistan 24
TR - Turchia 22
JP - Giappone 20
AT - Austria 19
VE - Venezuela 19
CH - Svizzera 17
CO - Colombia 15
ID - Indonesia 15
CZ - Repubblica Ceca 14
NG - Nigeria 14
EC - Ecuador 13
IR - Iran 13
GR - Grecia 12
CI - Costa d'Avorio 11
IL - Israele 10
LT - Lituania 10
SA - Arabia Saudita 10
CL - Cile 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
PT - Portogallo 8
PY - Paraguay 8
JO - Giordania 7
MA - Marocco 7
PE - Perù 7
SI - Slovenia 7
TH - Thailandia 7
AZ - Azerbaigian 6
BO - Bolivia 6
CR - Costa Rica 6
EG - Egitto 6
ET - Etiopia 6
MY - Malesia 6
AU - Australia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
JM - Giamaica 5
NP - Nepal 5
PH - Filippine 5
RO - Romania 5
AL - Albania 4
GE - Georgia 4
KZ - Kazakistan 4
TN - Tunisia 4
UY - Uruguay 4
DK - Danimarca 3
GT - Guatemala 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
MD - Moldavia 2
MT - Malta 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
ZM - Zambia 2
AM - Armenia 1
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
HU - Ungheria 1
Totale 15.487
Salva come PNG Salva come JPEG
Città #
Dallas 720
Dublin 636
Southend 553
Singapore 522
Ashburn 515
Fairfield 481
San Jose 386
Chandler 332
Moscow 330
Santa Clara 320
Milan 297
Siena 267
Beijing 239
Hong Kong 234
Woodbridge 220
Hefei 195
Jacksonville 176
Seattle 164
Ann Arbor 161
Seoul 159
Cambridge 155
Houston 155
Helsinki 154
Council Bluffs 147
Munich 144
Wilmington 141
Rome 133
Los Angeles 128
New York 109
Princeton 97
Johannesburg 85
Florence 83
Ho Chi Minh City 81
The Dalles 77
Lauterbourg 75
Hanoi 73
Dong Ket 68
Lappeenranta 64
Nanjing 58
Elk Grove Village 49
São Paulo 46
Orem 40
Buffalo 34
Shanghai 34
London 32
San Mateo 32
Boardman 30
Columbus 30
Frankfurt am Main 28
Montreal 27
San Diego 27
Chicago 26
Brussels 24
Denver 23
Menlo Park 22
Phoenix 22
Turku 22
Bengaluru 21
Düsseldorf 21
Nuremberg 21
Shenyang 21
Tashkent 21
Chennai 20
Tokyo 20
Redondo Beach 19
Warsaw 19
Figino 18
Lancaster 18
Toronto 17
Málaga 16
Washington 16
Atlanta 15
Bologna 15
Nanchang 15
San Francisco 15
Belo Horizonte 14
Dearborn 14
Messina 14
Piscataway 14
Fremont 13
Guangzhou 13
Haiphong 12
Hebei 12
Mumbai 12
Portsmouth 12
Abidjan 11
Abuja 11
Amsterdam 11
Brooklyn 11
Kunming 11
Naples 11
Paris 11
Redwood City 11
Baghdad 10
Boston 10
Brescia 10
Changsha 10
Da Nang 10
Madrid 10
Rio de Janeiro 10
Totale 10.098
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 371
Vaginal immunization to elicit primary T-cell activation and dissemination 334
Vaccination in the elderly: The challenge of immune changes with aging 332
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 325
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 317
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 307
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 302
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 297
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 289
Ebola vaccine R&D: Filling the knowledge gaps 289
Adoptive transfer of transgenic T cells to study mucosal adjuvants 285
Role of the microbiota in the modulation of vaccine immune responses 273
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 270
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 256
Bacillus spores for vaccine delivery 251
Modulation of Primary Immune Response by Different Vaccine Adjuvants 247
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 246
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 244
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 241
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 226
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 225
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 217
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 214
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 213
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 212
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 209
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 208
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 207
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 206
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 204
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 202
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 201
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 199
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 198
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 198
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 198
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 195
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 192
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 190
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 190
Primary T-cell response to mucosal vaccination 190
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 187
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 185
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 185
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 185
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 184
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 184
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 183
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 182
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot 179
Oral priming of mice by recombinant spores of Bacillus subtilis 178
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 178
Surface display of recombinant proteins on Bacillus subtilis spores 177
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 174
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 171
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 168
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 166
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 165
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study 165
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 164
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 164
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 161
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 158
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 154
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 149
Oral priming of mice using recombinant spores of Bacillus subtilis 147
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 145
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 140
Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers 129
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP 128
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 123
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach 121
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2 120
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 118
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 104
null 102
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae 75
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome 41
Machine learning approaches to dissect hybrid and vaccine-induced immunity 36
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial 34
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 24
TENTACLES: a consensus machine learning tool for robust biomarker discovery in heterogeneous data 17
Totale 15.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022646 0 0 43 59 29 14 44 28 44 80 115 190
2022/20231.223 77 142 173 136 103 220 41 104 88 31 81 27
2023/20241.202 33 34 100 79 55 307 367 43 24 65 25 70
2024/20252.606 80 97 271 138 313 166 144 161 269 111 244 612
2025/20265.946 459 796 593 763 1.079 217 586 188 250 359 204 452
2026/2027739 254 226 259 0 0 0 0 0 0 0 0 0
Totale 15.720